Eton Pharmaceuticals, Inc.
SEC CIK 1710340 · ETON · last insider filing 2026-06-30
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Adams Jennifer Mckie | Director | filed 2021 - 2026 |
| Brynjelsen Sean | Director · President & CEO | filed 2018 - 2026 |
| Riedel Norbert G | Director | filed 2018 - 2026 |
| Casamento Charles J | Director | filed 2018 - 2026 |
| Maier Paul V | Director | filed 2018 - 2026 |
| Baum Mark L | Director | filed 2018 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Krempa David | Chief Business Officer | filed 2023 - 2026 |
| Matthews Judith M. | Chief Financial Officer | filed 2026 - 2026 |
| Gruber James R. | Chief Financial Officer | filed 2022 - 2026 |
| Erdogan-Trinkaus Ipek | Chief Commercial Officer | filed 2024 - 2026 |
| Troutman William Wilson | CFO, Treasurer & Secretary | filed 2018 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.